Abivax S.A. Stock
Price
Target price
€6.27
€6.27
2.310%
0.14
2.310%
-
27.06.25 / Tradegate
WKN: A14UQC / Name: Abivax / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Financial data and news for Abivax
sharewise wants to provide you with the best news and tools for Abivax, so we directly link to the best financial data sources.
Financials
News
EQS-News: Abivax Announces Results of its June 6, 2025 Annual General Meeting
EQS-News: Abivax Announces Results of its June 6, 2025 Annual General Meeting
EQS-News: Abivax Presents First Quarter 2025 Financial Results
EQS-News: Abivax Presents First Quarter 2025 Financial Results
EQS-News: Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
EQS-News: Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
EQS-News: Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
EQS-News: Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
EQS-News: Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
EQS-News: Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
EQS-News: Abivax Announces Full Year 2024 Financial Results
EQS-News: Abivax Announces Full Year 2024 Financial Results
EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
EQS-News: Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025
EQS-News: Abivax Publishes 2025 Financial Calendar
EQS-News: Abivax Publishes 2025 Financial Calendar
EQS-News: Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
EQS-News: Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
EQS-News: Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
EQS-News: Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment